COVID-19
Researchers from Hyogo Medical University in Japan conducted a study to evaluate the humoral and cell-mediated immune responses induced by an inactivated influenza vaccine (IIV4) during the 2019/2020 influenza season. The study, which was supported by the Hyogo Medical University Grant For Research Promotion and the Japan Society For
COVID-19
A new study examining the vaccination compliance of Israeli nurses during the COVID-19 pandemic has found a significantly higher rate of COVID-19 vaccination compared to flu vaccination. The research, conducted by Ola Ali-Saleh and colleagues at Max Stern Yezreel Valley College, discovered that factors such as perceived susceptibility, perceived severity,
COVID-19
Researchers have analyzed confirmed COVID-19 cases and deaths in Fulton County, Georgia, between March 2020 and November 2021. The study found a positive association between social vulnerability index-plus (SVI+) and COVID-19 census tract-level case and death rates. The findings suggest that communities with higher social vulnerability experienced worse COVID-19 outcomes,
COVID-19
The COVID-19 pandemic has significantly increased global interest in antiviral therapies, and the demand for effective peptide therapeutics derived from natural substances is rapidly rising. Researchers at the Korea Institute of Science and Technology (KIST) have made a groundbreaking discovery by developing a therapeutic substance with both antiviral and tissue
COVID-19
New research published in AAPS PharmSciTech has made significant progress in developing a treatment for COVID-19, caused by the coronavirus SARS-CoV-2. The study, conducted by a team of researchers from Mercer University, focused on creating a nebulized Camostat Mesylate (Camo) loaded nanoliposome (Camo-pegNLs) for direct lung delivery to treat SARS-CoV-2
COVID-19
The COVID-19 pandemic remains a pressing concern globally due to the rapid emergence of new variants and the development of antiviral drug resistance. Despite mass vaccinations, the pandemic continues to unfold, with researchers emphasizing the urgent need for new antiviral strategies to combat SARS-CoV-2 infections. The use of nirmatrelvir has
COVID-19
A team of researchers at the University of Toledo has made a significant breakthrough in understanding the molecular determinants of the SARS-CoV-2 main protease (Mpro), a crucial enzyme for viral replication. The study, published in the journal Molecules, reveals that a systematic investigation into the molecular determinants of Mpro inhibition
COVID-19
The May announcement by U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. that the Centers for Disease Control and Prevention would stop recommending COVID-19 vaccinations for some people, including healthy pregnant women and healthy children over 6 months old, sparked confusion. Although the recommendation was
COVID-19
According to a recent study published in the journal Ginekologia Polska, despite robust scientific evidence supporting the safety and efficacy of vaccinations, trust in immunizations among pregnant women has been declining. The study aimed to present women's attitudes towards vaccinations against pertussis, influenza, and COVID-19 during pregnancy, their
COVID-19
A recent study published in the Infection Genetics and Evolution journal has shed light on the genetic diversity of respiratory syncytial virus (RSV) during a non-epidemic season in Shenzhen, China. According to the research, the RSV-G region contributes significantly to strain variation, which can lead to severe epidemics. The study
COVID-19
New research published in Frontiers in Public Health has shed light on the local epidemiology and pathogen spectrum of acute respiratory infections caused by common respiratory viruses other than influenza virus (IFV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Fujian Province, China, from September 2020 to December 2023.
COVID-19
Researchers at Monash University have made significant strides in developing mRNA therapeutics for various diseases, driven by the success of mRNA vaccines for COVID-19. The team introduced a novel lipid-polymer hybrid nanoparticle design, leveraging medium-chain-length polyhydroxyalkanoates (mcl-PHAs) as a sustainable alternative to conventional poly(lactic-co-glycolic acid) (PLGA). By combining the
